valuation of acute pain intensity and pain relief with analgesic techniques usually relies on patients' selfrating with visual analog or numeric rating scales (NRSs). [1] [2] [3] These scales are of no help in patients with impaired consciousness who are frequently encountered during the postoperative period or in patients with communication barriers, a growing issue for health care providers in Western multicultural and multilingual societies. 4 Behavioral pain scales have been developed for nonverbal patients, such as intensive care unit patients. 5 Unfortunately, no behavioral acute pain scale has been specifically developed for adult surgical patients. Additionally, ethnic or cultural differences may compromise the use of such a scale. 6 Thus, an objective tool to measure acute pain intensity or the effectiveness of analgesia would be of benefit to both patients and health care providers.
Increase in pupillary diameter (PD) is observed after application of an experimental noxious stimulus in anesthetized or sedated intensive care unit patients. 7, 8 This pupillary dilation reflex to pain is attenuated by IV opioids or inhaled nitrous oxide. [9] [10] [11] [12] It has therefore been proposed during general anesthesia as a tool to guide opioid administration. Similarly, pupillary light reflex amplitude (PLRA), the difference between PD before and after light exposure, increases after application of an experimental noxious stimulus in patients under general anesthesia. 7, 11, 13 However, to the best of our knowledge, no study has examined the effect of a natural, nonexperimental, noxious stimulus in conscious patients on PD and PLRA. Labor pain is an intense, nonexperimental, noxious stimulus that can be effectively relieved with lumbar epidural analgesia. Investigating the effects of labor pain and pain relief with epidural analgesia on PD and PLRA may therefore be a first step to evaluate pupillometry as a tool to assess acute spontaneous pain intensity and pain relief with analgesic techniques in conscious patients. Moreover, it could be helpful for the caregiver to determine in conscious patients whether a single pupillometry assessment can discriminate patients with pain from patients without pain to start an analgesic intervention rather than monitor the effect of an analgesic intervention with repeated pupillometry assessments.
BACKGROUND: Pain intensity is usually self-rated by patients with a numeric rating scale (NRS) but this scale cannot be used for noncommunicating patients. In anesthetized patients, experimental noxious stimulus increases pupillary diameter (PD) and pupillary light reflex amplitude (PLRA), the difference between PD before and after light stimulation. Labor pain is an intense acute nonexperimental stimulus, effectively relieved by epidural analgesia. In this prospective observational study, we therefore describe the effects of labor pain and pain relief with epidural analgesia on PD and PLRA, determine their association with pain intensity and determine the ability of a single measurement of PD or PLRA to assess pain. METHODS: In the first stage, pain , PD, and PLRA were measured in 4 conditions in 26 laboring women: before and after epidural analgesia and in the presence and absence of a uterine contraction. Pupillometry values among the 4 conditions were compared, and the strength of the association between absolute values of pain and PD or PLRA and between pain and changes in PD or PLRA brought about by uterine contraction was assessed with r 2 . In the second stage, 1 measurement was performed in 104 laboring women. The strength of the association between pain and PD or PLRA was assessed with r 2 . The ability of PD or PLRA to discriminate pain (NRS > 4) was also assessed. RESULTS: In the first stage, a statistically significant increase in pain, PD, and PLRA was observed during a contraction, and this change was abolished after epidural analgesia. The r 2 for the association between pain and changes in PD (r 2 = 0.25 [95% confidence interval, 0.07-0.46] or PLRA (r 2 = 0.34 [0.14-0.56]) brought about by a uterine contraction was higher than the r 2 for the association between pain and absolute values of PD (r 2 = 0.14 [0.04-0.28]) or PLRA (r 2 = 0.22 [0.10-0.37]) suggesting a stronger association for changes than for absolute values. In the second stage, r 2 was 0. 23 The goal of the first stage of this 2-stage observational study was, first, to describe the effects of labor pain and pain relief with epidural analgesia on PD and PLRA, and, second, to study the association between pain and PD or PLRA. The goal of the second stage was to determine the ability of a single measurement of PD or PLRA to discriminate laboring women with and without pain.
METHODS
This study was approved by the local IRB of Hotel-Dieu Hospital ("Comité pour la Protection des Personnes, Ile de France 1"), Assistance Publique-Hôpitaux de Paris, France. Informed written consent was obtained from each patient. The study took place in the Delivery Unit of Bichat Hospital, an academic hospital with 2200 deliveries per year and an 87% epidural analgesia rate.
Study Design
This was a 2-stage clinical study assessing laboring women in 4 conditions: no epidural analgesia, no uterine contraction (NoE/NoC); no epidural analgesia, during a uterine contraction (NoE/C); with epidural analgesia, no uterine contraction (E/NoC); with epidural analgesia, during a uterine contraction (E/C). Noninclusion criteria were contraindication to epidural analgesia, patient's refusal to participate, ocular disease, diabetes, hypertension, or preeclampsia.
In the first stage, a convenience sample of 25 women in labor was planned to be included. Pupillary and pain assessments were performed 4 times in each patient, before and after initiation of epidural analgesia, in the following order: NoE/NoC, NoE/C, E/NoC, and E/C. Each woman was used as her own control, and 2 paired samples were defined for each patient. The first paired sample was before epidural analgesia with 2 conditions (contraction or no contraction), and the second paired sample was after epidural analgesia with 2 conditions (contraction or no contraction).
In the second stage, inclusion of 100 laboring women was planned, with 25 patients in each of the 4 following conditions: NoE/NoC, NoE/C, E/NoC, and E/C. Once the number of patients in the first condition was obtained (NoE/NoC), patients in the second condition (NoE/C) were recruited and so on. Pupillary and pain assessment was performed once in each patient.
Lumbar Epidural Analgesia Technique
Epidural analgesia was initiated at the request of the patient without regard to stage of labor or cervical dilation at the time of the request. The procedure was performed in the sitting position using a midline approach and loss-of-resistance to saline technique. Five minutes after a test dose of 2 mL of lidocaine 20 mg/mL without epinephrine, 5 µg of sufentanil, and 5 mL of ropivacaine 1 mg/mL were injected through the epidural catheter. Ten minutes after the test dose, a second bolus of 5 mL of ropivacaine 1 mg/mL was administered. Thirty minutes after the test dose, patientcontrolled epidural analgesia (ropivacaine 1 mg/mL with sufentanil 0.25 µg/mL) was initiated (patient bolus: 5 mL; lockout interval: 10 minutes; basal infusion rate: 1-5 mL/h; maximal volume: 30 mL/h).
Pupillary Assessment
Pupillary assessment was performed with an infrared portable dynamic video pupillometer (Neurolight®, IDMed Company, Marseilles, France). 14 One assessment consisted of a 5-second video recording of PD with a sampling frequency of 67 Hertz (i.e., a PD recorded every 15 milliseconds). During the 5-second video recording, flashlight stimulation was applied to elicit the pupillary light reflex, and the PD before and after the flashlight calculated. Flashlight illumination was 320 Lux, and luminance was 1280 Candela/m 2 .
PD before the flashlight stimulation was obtained during the interval beginning 0.4 seconds before the flashlight and ending with the flashlight (i.e., a 400-millisecond interval with 27 PDs recorded). PD before the flashlight was defined as the median of the 6 highest PDs among the 27 diameters recorded during this interval. PD after the flashlight was obtained during the interval beginning 0.3 seconds after the flashlight and ending 1.3 seconds after the flashlight (i.e., a 1000-millisecond interval with 67 PDs recorded). PD after the flashlight was defined as the median of the 6 lowest PDs among the 67 diameters recorded during this interval. PLRA was calculated as the difference between PD before the flashlight and PD after the flashlight stimulation. Retinal illuminance (i.e., the measure of light stimulus that drives the pupil into contraction) was calculated as luminance multiplied by pupil area before the flashlight.
To avoid the influence of ambient lighting in the room on pupillary light reflex, the pupillometer included a preformed silicone membrane surrounding the orbit under investigation. During the recording, patients stayed in a half-sitting position, with the eyes under investigation looking straight ahead. A video recording was performed as follows: the pupillometer was applied to the orbit, then the patient was asked to close the contralateral eye, and the recording started. When the patient was not able to close the contralateral eye during the pupil scan, it was closed by the investigator by applying a gentle downward traction on the superior eyelid. Blinking during pupil scan was detected by the visual inspection of the recording; these recordings were discarded and the recording repeated.
One 5-second pupillary assessment was performed once in each of the 4 conditions (NoE/NoC, NoE/C, E/NoC, and E/C). The recording during a contraction started at the beginning of the increase in intrauterine pressure identified on an external tocodynamometer. The recording with epidural analgesia was performed at least 30 minutes after the test dose.
Pain Assessment
At the completion of pupil scan, pain intensity was assessed by the patient with an 11-point NRS (0 = "no pain," 10 = "the worst imaginable pain"). 2,3 A value >4 defined pain.
Statistical Analysis
The results are presented as number of patients (%), or mean ± SD (range). When appropriate, 95% confidence intervals [95% CIs] were calculated. Statistical analyses were performed using the R software, version 2.14.1 (R Foundation for Statistical Computing, Vienna, Austria). P < 0.05 was considered significant.
To compare pain, PD, or PLRA among the 4 conditions, we first performed an analysis of covariance with a global test for the difference among conditions considering repetition within patients. If this global test was significant, we performed 3 paired t tests to compare NoE/C versus NoE/NoC, E/NoC versus NoE/NoC and E/C versus E/NoC, with P values adjusted with the Holm correction. An adjusted P < 0.05 was considered significant. Each analysis of covariance was also completed by an analysis including the baseline value of pain, PD, or PLRA, respectively, as a covariate to test the influence of baseline. Moreover, for PLRA, an analysis of covariance including retinal illuminance as a covariate was also performed to determine whether PLRA values were related to retinal illuminance changes resulting from pupil size area changes.
The relationship between pain (NRS) and absolute values of PD was assessed with a linear mixed-effects model, since repeated measurements within patient (i.e., the 4 conditions) were analyzed. We assumed uncorrelated additive error and a normally distributed patient intercept random effect. A similar analysis was performed for PLRA. We also used a linear mixed-effects model to study the relationship between NRS and changes in PD brought about by a uterine contraction (C minus NoC) in the 2 conditions (E or NoE). A similar analysis was performed for PLRA. Performance of each model was assessed with the Bayesian information criterion (BIC). A lower value of the BIC indicates a better model performance, and a difference of BIC >10 between 2 models suggests very strongly that the model with the lower BIC is better. 15 Strength of the association was assessed with the specific r 2 for mixedeffects models, the square of the correlation coefficient r between the observed and fitted values of pain in the model, and its 95% CI. 16 This value indicates the proportion of the variation of pain accounted for by the linear mixed-effects model.
In the second stage, inclusion of 100 patients was based on an expected correlation coefficient r of 0.35 between PLRA and NRS. To obtain a power of 90% with a type 1 error of 5%, at least 82 patients had to be included (i.e., at least 20 patients per group). The association between pain (NRS) and PD or PLRA in the 4 independent groups of patients combined (NoE/NoC, NoE/C, E/NoC, and E/C) was assessed with linear regression and the strength of the association with the coefficient of determination r 2 . The ability of PD or PLRA to discriminate patients with and without pain (NRS > 4 and NRS ≤ 4, respectively) was assessed with the area under the receiver operating characteristics curve (AUC). 1 Comparison of the AUC used the DeLong method. The 95% CI of the difference between the 2 AUC was calculated with bootstrap resampling (b = 2000) and the percentiles method.
RESULTS
Twenty-six patients were included in the first stage, and 104 patients in the second stage. Their characteristics are presented in Table 1 . No patient complained of having a light flashed into her eyes.
First Stage
Pain (NRS), PD, and PLRA measurements in the 4 conditions (NoE/NoC, NoE/C, E/NoC, and E/C) are summarized in Figure 1 . Analysis of covariance demonstrated a significant difference for pain, PD, and PLRA (P < 0.0001 for pain, PD, and PLRA). Analysis of covariance results were unchanged when incorporating baseline values of pain, PD, or PLRA. The difference for PLRA remained significant in the analysis of covariance including retinal illuminance as a covariate (P = 0.002).
In the first paired sample before epidural analgesia, a significant increase in pain (mean difference, 7.3 [95% CI, 7.2-8.5]), in PD (+14% [10] [11] [12] [13] [14] [15] [16] [17] [18] ), and in PLRA (+43%[31-55]) was observed during a uterine contraction when compared with no uterine contraction. In the second paired sample after epidural analgesia, a small but significant increase in pain during uterine contraction was observed when compared with no uterine contraction (mean difference, 1.5 [1.0-2.3]). One patient had an NRS >4 during the contraction. However, no significant changes in PD and PLRA were observed during uterine contraction when compared with no uterine contraction.
In the absence of contraction, a statistically significant decrease in pain (mean difference, −0.5 [−0.6 to −0.1]) was observed after epidural analgesia when compared with before epidural analgesia. No patient in the absence of contraction had an NRS value >4. A similar decrease in PD (−10%[−15 to −4]) but not in PLRA (−5%; [−16 to 6]) was observed.
Graphical displays of the relationships between the 104 absolute values (all the conditions combined) of pain and PD or PLRA are presented in the upper panel of Figure 2 . A significant relationship between pain and PD and between pain and PLRA was observed with linear mixed-effects models (P = 0.0001 and P < 0.0001, respectively). Values for r 2 were 0.14 [0.04-0.28] for PD and 0.22 [0.10-0.37] for PLRA. The BIC was 554 for PD and 542 for PLRA.
Graphical displays of the relationships between pain and the 52 changes in PD or PLRA (C minus NoC) in the 2 paired samples are presented in the lower panel of Figure  2 . A significant relationship between pain and PD changes and between pain and PLRA changes was observed with linear mixed-effects models (P = 0.0004 and P < 0.0001, respectively). The values for r 2 were 0.25 [0.07-0.46] for PD changes and 0.34 [0.14-0.56] for PLRA changes. The BIC was 278 for PD and 272 for PLRA.
Second Stage
Pain (NRS), PD, and PLRA measurements in the 4 groups of the validation stage are presented in Table 2 . A significant 
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Pupillometry and Labor Pain relationship between pain and PD (P < 0.0001) and between pain and PLRA (P < 0.0001) was observed with linear regression (Fig. 3 
DISCUSSION
Increase in PD and PLRA after application of an experimental noxious stimulus has been thoroughly investigated in anesthetized patients but less is known in nonanesthetized patients. [7] [8] [9] [10] [11] 13 In conscious healthy volunteers, Ellermeier and Westphal 17 and Höfle et al. 18 reported that pupillary dilation occurs after application of pressure on the fingers, and Oka et al. 12 reported that this response is attenuated by analgesic drugs such as inhaled nitrous oxide. Similarly, Aissou et al. 14 observed a pupillary dilation in postoperative patients after application of a standardized noxious stimulus close to skin incision that was attenuated by IV morphine titration. However, to our knowledge, no study has examined the effect of a natural noxious stimulus such as labor pain on PD and PLRA in conscious patients and determined whether pupillometry could be used as a tool to assess pain in this population. Our study showed that, similar to surgical or experimental pain, a significant increase in PD and PLRA was observed during uterine contraction in the first paired sample before epidural analgesia. The increase in pain, PD, and PLRA during uterine contraction were abolished in the second paired sample after epidural analgesia. Since changes in PD and PLRA paralleled changes in pain, we hypothesized that pain associated with labor and pain relief with epidural analgesia were responsible for pupillometry measurement changes. However, increase in retinal illuminance resulting from pupillary dilation during uterine contraction may have been responsible for the observed increase in PLRA. The analysis of covariance considering retinal illuminance excluded this hypothesis. The relationship between pain and pupillary measurements was further confirmed by the association between pain and absolute values of PD or PLRA or between pain and changes in PD or PLRA brought about by a uterine contraction in the 2 paired samples. These results are similar to those in previous studies in anesthetized patients which demonstrated an attenuation of the dilation of the pupil or of the PLRA in response to an experimental noxious stimulus with analgesia. [9] [10] [11] 19 These changes constitute the rationale supporting the use of pupillometry to guide opioid administration during general anesthesia. The higher correlation coefficient for changes as compared with absolute values suggests that the association between pain and changes in PD or PLRA was stronger than the association between pain and absolute values of PD or PLRA. It also suggests that repeated pupillometry measurements to evaluate pain changes after an analgesic intervention may be more appropriate than a single pupillometry measurement to diagnose pain and decide an analgesic intervention.
In the absence of uterine contraction, a significant decrease in PD and a statistically significant but not clinically relevant decrease in pain were observed after epidural analgesia when compared with before epidural analgesia. We suggest that a direct effect of epidural opioids on pupil size is responsible for this decrease in PD, similar to the myosis induced by IV morphine in conscious patients without noxious stimulus. 20, 21 A direct effect of local anesthetic on pupil diameter is unlikely because it was demonstrated that IV administration of lidocaine to reach a plasma concentration of 5 µg/mL has no effect on PD. 22 The absence of decrease in PLRA may be explained by the decrease in both PD before the flashlight and PD after the flashlight, because PLRA is the difference between PD before and after the flashlight. We decided not to use a control group of patients without epidural sufentanil administration to specifically assess the effects of opioids on pupillary measurements because the use of sufentanil is our routine practice.
In the second stage, a weak association between absolute values of pain and PD or PLRA was observed. The ability of PD and PLRA to discriminate patients with and without pain had an AUC of 0.82 and 0.80, respectively. 23 This does not support our initial hypothesis that a single pupillometry assessment could identify patients with pain and help decide an analgesic intervention. It reinforces the suggestion that repeated pupillometry measurements may help monitor pain changes after an analgesic intervention and underlines the need for complementary studies.
It should be noted that all statistical analyses performed assumed normal distribution of the variables, which is unlikely for NRS because of the number of zero values. However, the statistical modeling was mainly exploratory and did not intend to make strong inferences. The 95% CI of r 2 also relies on this assumption and should be evaluated cautiously. The statistical methods used are rather robust with respect to departure from normality assumption.
Use of an NRS to assess pain intensity is limited by communication skills of the patients. These scales are of no help in case of impaired consciousness that is frequently encountered during the postoperative period or in case of communication barriers such as language barrier. 4 We have studied a very specific group of patients, women in labor, and they are not representative of all conscious patients experiencing pain. The results may therefore not be similar in other types of acute nonexperimental pain such as acute postoperative pain. This highlights the need for complementary studies. However, in our opinion, this study provides clinical evaluation for a tool that may be used to monitor the balance of nociception/analgesia in other situations with poorly communicating or noncommunicating patients such as sedated critically ill patients or drowsy patients in the postanesthesia care unit.
Bias may have resulted from the fact that the same investigator performed pupil scans and recorded patients' pain. However, evaluation of pupil size by the investigator Results are expressed as mean ± 1 SD (range) or number of patients (%). NRS = numeric rating scale; PD = pupillary diameter; PLRA = pupillary light reflex amplitude; NoE/NoC = no epidural analgesia, no uterine contraction; NoE/C = no epidural analgesia, during uterine contraction; E/NoC = epidural analgesia, no uterine contraction; E/C = epidural analgesia, during uterine contraction.
PD (mm)
Pain (NRS) is an objective measurement provided by the video pupillometer, and the investigator only recorded self-rated pain by the patient which did not require investigator interpretation. Moreover, pupil scans were made before measuring pain to minimize the bias resulting from knowledge of the status of the disease (i.e., pain or no pain). 24 In conclusion, changes in PD and PLRA are associated with pain brought about by a uterine contraction. These assessments may be a useful tool to monitor pain after an analgesic intervention in noncommunicating patients. Further studies are required to confirm this suggestion and determine its usefulness in other types of acute nonexperimental pain. E DISCLOSURES Name: Jean Guglielminotti, MD. Contribution: This author helped design and conduct the study, analyze the data, and write the manuscript. Attestation: Jean Guglielminotti has seen the original study data, reviewed the analysis of the data, approved the final manuscript, and is the author responsible for archiving the study files. Name: France Mentré, MD, PhD. Contribution: This author helped design the study, analyze the data, and write the manuscript. Attestation: France Mentré has seen the original study data, reviewed the analysis of the data, and approved the final manuscript. Name: Johann Gaillard, MD.
